USD 7.41
(19.71%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 589.7 Million USD | -51.57% |
2022 | 1.21 Billion USD | -15.79% |
2021 | 1.44 Billion USD | 5.03% |
2020 | 1.37 Billion USD | 175.39% |
2019 | 499.88 Million USD | 2.16% |
2018 | 489.31 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 482.98 Million USD | -4.89% |
2024 Q1 | 548.38 Million USD | -7.01% |
2024 Q2 | 507.82 Million USD | -7.4% |
2023 Q1 | 850.5 Million USD | -30.15% |
2023 FY | 589.7 Million USD | -51.57% |
2023 Q4 | 589.7 Million USD | -7.13% |
2023 Q3 | 635 Million USD | -17.76% |
2023 Q2 | 772.17 Million USD | -9.21% |
2022 Q2 | 1.29 Billion USD | -4.65% |
2022 Q1 | 1.36 Billion USD | -5.81% |
2022 FY | 1.21 Billion USD | -15.79% |
2022 Q4 | 1.21 Billion USD | -1.15% |
2022 Q3 | 1.23 Billion USD | -5.14% |
2021 FY | 1.44 Billion USD | 5.03% |
2021 Q4 | 1.44 Billion USD | -2.6% |
2021 Q3 | 1.48 Billion USD | 14.86% |
2021 Q2 | 1.29 Billion USD | -2.26% |
2021 Q1 | 1.32 Billion USD | -3.96% |
2020 Q1 | 480.9 Million USD | -3.8% |
2020 Q4 | 1.37 Billion USD | -2.64% |
2020 Q3 | 1.41 Billion USD | 137.09% |
2020 Q2 | 596.4 Million USD | 24.02% |
2020 FY | 1.37 Billion USD | 175.39% |
2019 FY | 499.88 Million USD | 2.16% |
2019 Q4 | 499.88 Million USD | 0.0% |
2018 FY | 489.31 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Doximity, Inc. | 1.07 Billion USD | 45.366% |
Evolent Health, Inc. | 2.68 Billion USD | 77.999% |
MultiPlan Corporation | 7.1 Billion USD | 91.701% |
Phreesia, Inc. | 371.08 Million USD | -58.914% |
Teladoc Health, Inc. | 4.39 Billion USD | 86.574% |
Veeva Systems Inc. | 5.91 Billion USD | 90.023% |